Flattening filter-free technique in volumetric modulated arc therapy for lung stereotactic body radiotherapy: A clinical comparison with the flattening filter technique

被引:22
|
作者
Aoki, Shuri [1 ]
Yamashita, Hideomi [1 ]
Haga, Akihiro [1 ]
Nawa, Kanabu [1 ]
Imae, Toshikazu [1 ]
Takahashi, Wataru [1 ]
Abe, Osamu [1 ]
Nakagawa, Keiichi [1 ]
机构
[1] Univ Tokyo Hosp, Dept Radiol, Tokyo 1138655, Japan
基金
日本学术振兴会;
关键词
flattening filter-free; stereotactic body radiotherapy; volumetric modulated arc therapy; lung cancer; radiation pneumonitis; RADIATION-THERAPY; EARLY-STAGE; OLIGO-RECURRENCE; TUMOR POSITION; PHOTON BEAMS; PHASE-II; CANCER; OLIGOMETASTASES; TRIAL; VERIFICATION;
D O I
10.3892/ol.2018.7809
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The present study sought to evaluate the impact of the flattening filter-free (FFF) technique in volumetric modulated arc therapy for lung stereotactic body radiotherapy. Its clinical safety and availability were compared with the flattening filter (FF) method. The cases of 65 patients who underwent lung volumetric modulated arc therapy-stereotactic body radiotherapy (VMAT-SBRT) using FF or FFF techniques were reviewed. A total of 55 Gy/4 fractions (fr) was prescribed for peripheral lesions or 56 Gy/7 fr for central lesions. The total monitor units (MU), treatment time, dose to tumors, dose to organs at risk, tumor control (local control rate, overall survival, progression-free survival) and adverse events between cases treated with FF and cases treated with the FFF technique were compared. A total of 35 patients were treated with conventional FF techniques prior to November 2014 and 30 patients were treated with FFF techniques after this date. It was revealed that the beam-on time was significantly shortened by the FFF technique (P<0.01). Other factors were similar for FFF and FF plans in respect to conformity (P=0.95), homogeneity (P=0.20) and other dosimetric values, including total MU and planning target volume/internal target volume coverage. The median follow-up period was 18 months (range, 2-35). One-year local control rates were 97.1 and 90.0% in the FF group and FFF groups, respectively (P=0.33). Grade 3 pneumonitis was observed in 5.8% of FF patients and 3.4% of FFF patients (P=1.00). No other adverse events >= grade 3 were observed. The results of the study suggest that VMAT-SBRT using the FFF technique shortens the treatment time for lung SBRT while maintaining a high local control rate with low toxicity.
引用
收藏
页码:3928 / 3936
页数:9
相关论文
共 50 条
  • [21] Stereotactic ablative radiation therapy for brain metastases with volumetric modulated arc therapy and flattening filter free delivery: feasibility and early clinical results
    Fiorentino, Alba
    Giaj-Levra, Niccolo
    Tebano, Umberto
    Mazzola, Rosario
    Ricchetti, Francesco
    Fersino, Sergio
    Di Paola, Gioacchino
    Aiello, Dario
    Ruggieri, Ruggero
    Alongi, Filippo
    RADIOLOGIA MEDICA, 2017, 122 (09): : 676 - 682
  • [22] The Use of Photon Beams of a Flattening Filter-free Linear Accelerator for Hypofractionated Volumetric Modulated Arc Therapy in Localized Prostate Cancer
    Zwahlen, Daniel R.
    Lang, Stephanie
    Hrbacek, Jan
    Glanzmann, Christoph
    Kloeck, Stephan
    Najafi, Yousef
    Streller, Tino
    Studer, Gabriela
    Zaugg, Kathrin
    Luetolf, Urs M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (05): : 1655 - 1660
  • [23] Stereotactic radiotherapy for lung cancer using a flattening filter free Clinac
    Vassiliev, Oleg N.
    Kry, Stephen F.
    Chang, Joe Y.
    Balter, Peter A.
    Titt, Uwe
    Mohan, Radhe
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2009, 10 (01): : 14 - 21
  • [24] Clinical experience of volumetric-modulated flattening filter free stereotactic body radiation therapy of lesions in the lung with deep inspiration breath-hold
    Morkeset, Siri T.
    Lervag, Christoffer
    Lund, Jo-Asmund
    Jensen, Christer
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2022, 23 (09):
  • [25] Flattening Filter Free vs. Flattened Beams for Lung Stereotactic Body Radiation Therapy
    Annede, Pierre
    Darreon, Julien
    Benkemouche, Ahcene
    Valdenaire, Simon
    Tyran, Marguerite
    Kaeppelin, Bertrand
    Macagno, Alban
    Barrou, Julien
    Cagetti, Leonel Varela
    Favrel, Veronique
    Moureau-Zabotto, Laurence
    Gonzague, Laurence
    Fau, Pierre
    Chargari, Cyrus
    Tallet, Agnes
    Salem, Naji
    ANTICANCER RESEARCH, 2017, 37 (09) : 5133 - 5139
  • [26] Dosimetric verification of stereotactic body radiation therapy for lung cancer treatment plans using flattening filter-free beams
    Zhang, Jiyong
    Wu, Vincent W.
    Lu, Jiayang
    Hong, Danli
    Lin, Zhixiong
    TUMORI JOURNAL, 2015, 101 (06): : 631 - 636
  • [27] Advanced nasopharyngeal carcinoma radiotherapy with volumetric modulated arcs and the potential role of flattening filter-free beams
    Zhuang, Mingzan
    Zhang, Tuodan
    Chen, Zhijian
    Lin, Zhixiong
    Li, Derui
    Peng, Xun
    Qiu, Qingchun
    Wu, Renhua
    RADIATION ONCOLOGY, 2013, 8
  • [28] Clinical application of flattening filter free beams for extracranial stereotactic radiotherapy
    Lang, Stephanie
    Shrestha, Binaya
    Graydon, Shaun
    Cavelaars, Frederique
    Linsenmeier, Claudia
    Hrbacek, Jan
    Kloeck, Stephan
    Studer, Gabriela
    Riesterer, Oliver
    RADIOTHERAPY AND ONCOLOGY, 2013, 106 (02) : 255 - 259
  • [29] Linac-based radiosurgery or fractionated stereotactic radiotherapy with flattening filter-free volumetric modulated arc therapy in elderly patients: Amono-institutional experience on 110 brain metastases
    Gregucci, Fabiana
    Fiorentino, Alba
    Corradini, Stefanie
    Figlia, Vanessa
    Mazzola, Rosario
    Ricchetti, Francesco
    Ruggieri, Ruggero
    Alongi, Filippo
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 (03) : 218 - 225
  • [30] Standardized flattening filter free volumetric modulated arc therapy plans based on anteroposterior width for total body irradiation
    Frederick, Rebecca
    Hudson, Alana
    Balogh, Alex
    Cao, Jeffrey Q.
    Pierce, Greg
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2020, 21 (03): : 75 - 86